Discover
DYN
Dyne Therapeutics, Inc.
16.64
2 x 11.54
2 x 19.90
bid
ask
+
0.27
1.65%
1 @ 04:00 AM
16.64 +0.00 (0.00%)
| Ytd | -14.93% | |
| 1y | 13.35% |
16.41
day range
17.31
13.72
52 week range
27.30
| Open | 16.41 | Prev Close | 16.37 | Low | 16.41 | High | 17.31 | Mkt Cap | 3.11B |
| Vol | 3.57M | Avg Vol | 2.88M | EPS | -3.30 | P/E | N/A | Forward P/E | -4.99 |
| Beta | 1.12 | Short Ratio | 8.04 | Inst. Own | 103.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 21.58 | 200-d Avg | 19.52 | 1yr Est | 35.73 |
DYN News
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market ses
benzinga.com
HC Wainwright & Co. Maintains Buy on Dyne Therapeutics, Lowers Price Target to $32
HC Wainwright & Co. analyst Ananda Ghosh maintains Dyne Therapeutics (NASDAQ:DYN) with a Buy
benzinga.com
Dyne Therapeutics Announces Additional One-Year Clinical Data From Phase 1/2 ACHIEVE Trial
- Data from a pooled dose group of participants initially enrolled in the multiple ascending dose (M
benzinga.com
Piper Sandler Reiterates Overweight on Dyne Therapeutics, Maintains $47 Price Target
Piper Sandler analyst Edward Tenthoff reiterates Dyne Therapeutics (NASDAQ:DYN) with a Overweight